163 related articles for article (PubMed ID: 10779402)
1. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
Balasa B; Van Gunst K; Sarvetnick N
Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
[TBL] [Abstract][Full Text] [Related]
2. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
3. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
4. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
5. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
7. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
8. Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor.
Suri A; Shimizu J; Katz JD; Sakaguchi S; Unanue ER; Kanagawa O
Eur J Immunol; 2004 Feb; 34(2):447-54. PubMed ID: 14768049
[TBL] [Abstract][Full Text] [Related]
9. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes.
Gonzalez A; Andre-Schmutz I; Carnaud C; Mathis D; Benoist C
Nat Immunol; 2001 Dec; 2(12):1117-25. PubMed ID: 11713466
[TBL] [Abstract][Full Text] [Related]
10. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
[TBL] [Abstract][Full Text] [Related]
11. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
Brown GR; Silva MD; Thompson PA; Beutler B
Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
[TBL] [Abstract][Full Text] [Related]
15. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of PDL1-mediated regulation of autoimmune diabetes.
Guleria I; Gubbels Bupp M; Dada S; Fife B; Tang Q; Ansari MJ; Trikudanathan S; Vadivel N; Fiorina P; Yagita H; Azuma M; Atkinson M; Bluestone JA; Sayegh MH
Clin Immunol; 2007 Oct; 125(1):16-25. PubMed ID: 17627890
[TBL] [Abstract][Full Text] [Related]
18. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
Jaakkola I; Jalkanen S; Hänninen A
Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
[TBL] [Abstract][Full Text] [Related]
20. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
